The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cells

Journal of Molecular Histology

Volumn 38, Issue 5, 2007, Pages 459-468

  Luong Van, Emma ^a,b   Grøndahl, Lisbeth ^b   Song, ShuJun ^a   Nurcombe, Victor ^a,c   Cool, Simon ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Proteoglycans; Regenerative medicine; Wound repair

Indexed keywords

HEPARAN SULFATE; POLYCAPROLACTONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMPLANTATION; IN VIVO STUDY; MACROPHAGE; MESENCHYME CELL; MOUSE; NONHUMAN; NUDE RAT; PRIORITY JOURNAL; RAT; STEM CELL; TISSUE ENGINEERING; WOUND HEALING;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL PROLIFERATION; CELLS, CULTURED; CONNECTIVE TISSUE; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RATS; RATS, NUDE; RECEPTORS, CELL SURFACE; TISSUE ENGINEERING; TRANSPLANTATION, HETEROLOGOUS; WOUND HEALING;

RATTUS;

EID: 35848965935     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-007-9129-y     Document Type: Article

References (50)

1. Ali SA, Doherty PJ, Williams DF (1994) Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo. Biomaterials 15:779-785
2. Blanquaert F, Barritault D, Caruelle JP (1999) Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res 44:63-72
3. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE (1998) Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273:4350-4359
4. Burger D, Dayer JM (2002) Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-alpha production in contact-mediated activation of monocytes by T lymphocytes. Ann NY Acad Sci 966:464-473
5. Dayoub H, Dumont RJ, Li JZ, Dumont AS, Hankins GR, Kallmes DF, Helm GA (2003) Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. Tissue Eng 9:347-356
6. De Jong WH, Bergsma JE, Robinson JE, Bos RRM (2005) Tissue response to partially in vitro predegraded poly-L-lactide implants. Biomaterials 26:1781-1791
7. Dijkstra CD, Döpp EA, Joling P, Kraal G (1985) The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 54:589-599
8. Hagerty RD, Salzmann DL, Kleinert LB, Williams SK (2000) Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethyleneterephthalate. J Biomed Mater Res 49:489-497
9. Hausser HJ, Brenner RE (2004) Low doses and high doses of heparin have different effects on osteoblast-like Saos-2 cells in vitro. J Cell Biochem 91:1062-1073
10. Hernandez-Pando R, Bornstein QL, Aguilar Leon D, Orozco EH, Madrigal VK, Martinez Cordero E (2000) Inflammatory cytokine production by immunological and foreign body multinucleated giant cells. Immunology 100:352-358
11. Hu WJ, Eaton JW, Ugarova TP, Tang L (2001) Molecular basis of biomaterial-mediated foreign body reactions. Blood 98:1231-1238
12. Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC (2001) Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res 55:203-216
13. Irie A, Habuchi H, Kimata K, Sanai Y (2003) Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem Biophys Res Commun 308:858-865
14. Jackson RA, McDonald MM, Nurcombe V, Little DG, Cool SM (2006) The use of heparan sulfate to augment fracture repair in a rat fracture model. J Orthop Res 24:636-644
15. Jackson RA, Murali S, van Wijnen AJ, Stein GS, Nurcombe V, Cool SM (2007) Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol 210:38-50
16. Kasten P, Vogel J, Luginbuhl R, Niemeyer P, Tonak M, Lorenz H, Helbig L, Weiss S, Fellenberg J, Leo A et al (2005) Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials 26:5879-5889
17. Kim KH, Jeong L, Park HN, Shin SY, Park WH, Lee SC, Kim TI, Park YJ, Seol YJ, Lee YM et al (2005) Biological efficacy of silk fibroin nanofiber membranes for guided bone regeneration. J Biotechnol 120:327-339
18. Kresse H, Schönherr E (2001) Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 198:266-274
19. Lafont J, Blanquaert F, Colombier ML, Barritault D, Carueelle JP, Saffar JL (2004) Kinetic study of early regenerative effects of RGTA11, a heparan sulfate mimetic, in rat craniotomy defects. Calcif Tissue Int 75:517-525
20. Li C, Vepari C, Jin HJ, Kim HJ, Kaplan DL (2006) Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials 27:3115-3124
21. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FK (2002) Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res 60:613-621
22. Li WJ, Tuli R, Okafor C, Derfoul A, Danielson KG, Hall DJ, Tuan RS (2005) A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26:599-609
23. Lindahl U, Lidholt K, Spillmann D, Kjellen L (1994) More to "heparin" than anticoagulation. Thromb Res 75:1-32
24. Luong-Van E, Grondahl L, Chua KN, Leong KW, Nurcombe V, Cool SM (2006) Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials 27:2042-2050
25. Luong-Van E, Grondahl L, Nurcombe V, Cool S (2007) In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. Biomaterials 28:2127-2136
26. Marques AP, Reis RL, Hunt JA (2005) An in vivo study of the host response to starch-based polymers and composites subcutaneously implanted in rats. Macromol Biosci 5:775-785
27. Ng KW, Hutmacher DW, Schantz JT, Ng CS, Too HP, Lim TC, Phan TT, Teoh SH (2001) Evaluation of ultra-thin poly(epsilon-caprolactone) films for tissue-engineered skin. Tissue Eng 7:441-455
28. Nurcombe V, Ford MD, Wildschut JA, Bartlett PF (1993) Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science 260:103-106
29. Ornitz DM (2000) FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22:108-112
30. Pitt CG, Gratzl MM, Kimmel GL, Surles J, Schindler A (1981) Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone) , and their copolymers in vivo. Biomaterials 2:215-220
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
32. Rai B, Teoh SH, Hutmacher DW, Cao T, Ho KH (2005) Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials 26:3739-3748
33. Rapraeger AC, Krufka A, Olwin BB (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705-1708
34. Rhodes NP, Hunt JA, Williams DF (1997) Macrophage subpopulation differentiation by stimulation with biomaterials. J Biomed Mater Res 37:481-488
35. Rosengren A, Danielsen N, Bjursten LM (1997) Inflammatory reaction dependence on implant localization in rat soft tissue models. Biomaterials 18:979-987
36. Sarkar S, Lee GY, Wong JY, Desai TA (2006) Development and characterization of a porous micro-patterned scaffold for vascular tissue engineering applications. Biomaterials 27:4775-4782
37. Shin M, Ishii O, Sueda T, Vacanti JP (2004a) Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 25:3717-3723
38. Shin M, Yoshimoto H, Vacanti JP (2004b) In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 10:33-41
39. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79:1015-1024
40. Sun TC, Mori S, Roper J, Brown C, Hooser T, Burr DB (1992) Do different fluorochrome labels give equivalent histomorphometric information? Bone 13:443-446
41. Sung HJ, Meredith C, Johnson C, Galis ZS (2004) The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 25:5735-5742
42. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R (2003) Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278:43229-43235
43. Tang L, Eaton JW (1993) Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med 178:2147-2156
44. van Luyn MJ, Khouw IM, van Wachem PB, Blaauw EH, Werkmeister JA (1998) Modulation of the tissue reaction to biomaterials. II. The function of T cells in the inflammatory reaction to crosslinked collagen implanted in T-cell-deficient rats. J Biomed Mater Res 39:398-406
45. Vos JG, Berkvens JM, Kruijt BC (1980) The athymic nude rat. I. Morphology of lymphoid and endocrine organs. Clin Immunol Immunopathol 15:213-228
46. Xia Z, Taylor PR, Locklin RM, Gordon S, Cui Z, Triffitt JT (2006) Innate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice. J Cell Biochem 98:966-980
47. Yang Q, Chen L, Shen XY, Tan ZQ (2006) Preparation of polycaprolactone tissue engineering scaffolds by improved solvent casting/particulate leaching method. J Macromol Sci B Phys 45:1171-1181
48. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848
49. Yoshimoto H, Shin YM, Terai H, Vacanti JP (2003) A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 24:2077-2082
50. Zhou Y, Chen F, Ho ST, Woodruff MA, Lim TM, Hutmacher DW (2007) Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts. Biomaterials 28:814-824